XBRA

COM:XBRANE

Xbrane Biopharma

  • Stock

Last Close

0.20

21/11 16:29

Market Cap

339.03M

Beta: -

Volume Today

8.50M

Avg: -

  • locale

    seSweden
  • market

    STOCKS
  • industry

    Biotechnology
  • website

    xbrane.com
  • ipo date

    Feb 03, 2016

Xbrane Biopharma AB (publ), a biotechnology company, develops, manufactures, and sells biosimilars. The company is developing Xlucane, a ranibizumab biosimilar that is in Phase III clinical trials used for the treatment of wet age-related macular degeneration, diabetic macular edema, diabetic related retinopathy, and retinal vein occlusion. Its pre-clinical phase products inclu...Show More

peer of

competitor of